• Mon espace de travail
  • Aide IRIS
  • Par Publication Par Personne Par Unité
    • English
    • Français
  • Se connecter
Logo du site

IRIS | Système d’Information de la Recherche Institutionnelle

  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
UNIL
  • English
  • Français
Se connecter
IRIS
  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
  • Mon espace de travail
  • Aide IRIS

Parcourir IRIS

  • Par Publication
  • Par Personne
  • Par Unité
  1. Accueil
  2. IRIS
  3. Publication
  4. Enantiospecific pharmacokinetics of intravenous dexmedetomidine in beagles.
 
  • Détails
Titre

Enantiospecific pharmacokinetics of intravenous dexmedetomidine in beagles.

Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Journal of Veterinary Pharmacology and Therapeutics  
Auteur(s)
Levionnois, O.L.
Auteure/Auteur
Barbarossa, A.
Auteure/Auteur
Bardhi, A.
Auteure/Auteur
Siegenthaler, J.
Auteure/Auteur
Forss Pleyers, T.
Auteure/Auteur
Guidi, M.
Auteure/Auteur
Spadavecchia, C.
Auteure/Auteur
Raillard, M.
Auteure/Auteur
Liens vers les personnes
Guidi, Monia  
Liens vers les unités
Laboratoires de pharmacologie  
Sciences pharmaceutiques cliniques  
ISSN
1365-2885
Statut éditorial
Publié
Date de publication
2022-07
Volume
45
Numéro
4
Première page
366
Dernière page/numéro d’article
372
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
The goal of this study was to investigate the pharmacokinetic (PK) behaviour of dexmedetomidine in dogs administered as a pure enantiomer versus as part of a racemic mixture. Eight unmedicated intact purpose-bread beagles were included. Two intravenous treatments of either medetomidine or dexmedetomidine were administered at 10- to 14-day intervals. Atipamezole or saline solution was administered intramuscularly 45 min later. Venous blood samples were collected into EDTA collection tubes, and the quantification of dexmedetomidine and levomedetomidine was performed by chiral LC-MS/MS. All dogs appeared sedated after each treatment without complication. Plasma concentrations of levomedetomidine were measured only in the racemic group and were 51.4% (51.4%-56.1%) lower than dexmedetomidine. Non-compartmental analysis (NCA) was performed for both drugs, while dexmedetomidine data were further described using a population pharmacokinetic approach. A standard two-compartment mammillary model with linear elimination with combined additive and multiplicative error model for residual unexplained variability was established for dexmedetomidine. An exponential model was finally retained to describe inter-individual variability on parameters of clearance (Cl <sub>1</sub> ) and central and peripheral volumes of distribution (V <sub>1</sub> , V <sub>2</sub> ). No effect of occurrence, levomedetomidine or atipamezole could be observed on dexmedetomidine PK parameters. Dexmedetomidine did not undergo significantly different PK when administered alone or as part of the racemic mixture in otherwise unmedicated dogs.
Sujets

Animals

Chromatography, Liqui...

Dexmedetomidine

Dogs

Hypnotics and Sedativ...

Infusions, Intravenou...

Medetomidine

Tandem Mass Spectrome...

dexmedetomidine

dog

medetomidine

pharmacokinetic

stereoselective

PID Serval
serval:BIB_F2C44CF39F4A
DOI
10.1111/jvp.13063
PMID
35484944
WOS
000788499900001
Permalien
https://iris.unil.ch/handle/iris/232958
Open Access
Oui
Date de création
2022-05-13T16:18:20.094Z
Date de création dans IRIS
2025-05-21T05:15:26Z
Fichier(s)
En cours de chargement...
Vignette d'image
Nom

35484944_BIB_F2C44CF39F4A.pdf

Version du manuscrit

published

Licence

https://creativecommons.org/licenses/by-nc/4.0

Taille

1.2 MB

Format

Adobe PDF

PID Serval

serval:BIB_F2C44CF39F4A.P001

URN

urn:nbn:ch:serval-BIB_F2C44CF39F4A8

Somme de contrôle

(MD5):1227de429f63969268adf34687fc15be

  • Copyright © 2024 UNIL
  • Informations légales